China Resources Pharmaceutical Group Limited (3320.HK)
HKD 5.29
(0.0%)
HKD 5.29
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 35.09 Billion HKD | 18.09% |
| 2022 | 29.71 Billion HKD | 0.1% |
| 2021 | 29.68 Billion HKD | 20.76% |
| 2020 | 24.58 Billion HKD | 10.09% |
| 2019 | 22.33 Billion HKD | 3.74% |
| 2018 | 21.52 Billion HKD | 0.57% |
| 2017 | 21.4 Billion HKD | 13.51% |
| 2016 | 18.85 Billion HKD | 23.65% |
| 2015 | 15.25 Billion HKD | -2.92% |
| 2014 | 15.71 Billion HKD | 28.8% |
| 2013 | 12.19 Billion HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 39.75 Billion HKD | 0.0% |
| 2023 FY | 35.09 Billion HKD | 18.09% |
| 2023 Q4 | 31.87 Billion HKD | 0.0% |
| 2023 Q2 | 34.88 Billion HKD | 0.0% |
| 2022 FY | 29.71 Billion HKD | 0.1% |
| 2022 Q2 | 29.08 Billion HKD | 0.0% |
| 2022 Q4 | 29.71 Billion HKD | 0.0% |
| 2021 Q4 | 29.68 Billion HKD | 0.0% |
| 2021 Q2 | 27.12 Billion HKD | 0.0% |
| 2021 FY | 29.68 Billion HKD | 20.76% |
| 2020 Q4 | 24.58 Billion HKD | 0.0% |
| 2020 Q2 | 24.65 Billion HKD | 0.0% |
| 2020 FY | 24.58 Billion HKD | 10.09% |
| 2019 Q4 | 22.33 Billion HKD | 0.0% |
| 2019 FY | 22.33 Billion HKD | 3.74% |
| 2019 Q2 | 22.73 Billion HKD | 0.0% |
| 2018 FY | 21.52 Billion HKD | 0.57% |
| 2018 Q4 | 21.52 Billion HKD | 0.0% |
| 2018 Q2 | 22.7 Billion HKD | 0.0% |
| 2017 Q4 | 21.4 Billion HKD | 0.0% |
| 2017 FY | 21.4 Billion HKD | 13.51% |
| 2017 Q2 | 20.78 Billion HKD | 0.0% |
| 2016 Q2 | 16.2 Billion HKD | 0.0% |
| 2016 Q4 | 18.85 Billion HKD | 0.0% |
| 2016 FY | 18.85 Billion HKD | 23.65% |
| 2015 FY | 15.25 Billion HKD | -2.92% |
| 2015 Q4 | 15.25 Billion HKD | 0.0% |
| 2014 FY | 15.71 Billion HKD | 28.8% |
| 2013 FY | 12.19 Billion HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -287635.377% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | -2427.282% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -482970.627% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -11290.882% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -8027.888% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -11672.685% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -55764.389% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -35614.368% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -19886.151% |
| SSY Group Limited | 1.08 Billion HKD | -3130.752% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -38219.682% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -10941.154% |